Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies
出版年份 2016 全文链接
标题
Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies
作者
关键词
-
出版物
Cell Death & Disease
Volume 7, Issue 9, Pages e2380-e2380
出版商
Springer Nature
发表日期
2016-09-29
DOI
10.1038/cddis.2016.297
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition
- (2015) Fumiyuki Sato et al. CANCER BIOLOGY & THERAPY
- Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives
- (2015) Joan Minguet et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic alterations in lung adenocarcinoma
- (2015) Siddhartha Devarakonda et al. LANCET ONCOLOGY
- Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
- (2015) Chee-Seng Tan et al. LANCET ONCOLOGY
- Refining the treatment of NSCLC according to histological and molecular subtypes
- (2015) Anish Thomas et al. Nature Reviews Clinical Oncology
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
- (2015) Yi-Nan Liu et al. Oncotarget
- Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
- (2015) Duane H. Hamilton et al. Oncotarget
- A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
- (2015) Alessandro Russo et al. Oncotarget
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
- (2015) C. R. Heery et al. Cancer Immunology Research
- Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
- (2015) Duane H. Hamilton et al. Oncotarget
- Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis
- (2014) Jo A. Tucker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- EGFR Blockade Enriches for Lung Cancer Stem-like Cells through Notch3-Dependent Signaling
- (2014) R. R. Arasada et al. CANCER RESEARCH
- WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial-Mesenchymal Transition
- (2014) D. H. Hamilton et al. CANCER RESEARCH
- Tumor Plasticity Interferes with Anti-Tumor Immunity
- (2014) Salem Chouaib et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Pharmacotherapy targeting the EGFR oncogene in NSCLC
- (2014) Lorenza Landi et al. EXPERT OPINION ON PHARMACOTHERAPY
- EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition
- (2014) Audrey Clapéron et al. JOURNAL OF HEPATOLOGY
- Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis
- (2014) Claudia Palena et al. JNCI-Journal of the National Cancer Institute
- EGFR-mediated tumor immunoescape
- (2014) Fernando Concha-Benavente et al. OncoImmunology
- Expression of Brachyury Gene Is a Significant Prognostic Factor for Primary Lung Carcinoma
- (2013) Akira Haro et al. ANNALS OF SURGICAL ONCOLOGY
- EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction
- (2013) Intissar Akalay et al. Autophagy
- Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
- (2013) Caroline Jochems et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
- (2013) I. Akalay et al. CANCER RESEARCH
- Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients
- (2013) Monic Roengvoraphoj et al. CANCER TREATMENT REVIEWS
- Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
- (2012) M. Roselli et al. CLINICAL CANCER RESEARCH
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Influence of IL-8 on the epithelial–mesenchymal transition and the tumor microenvironment
- (2012) Claudia Palena et al. Future Oncology
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- EGFR inhibitors sensitize non-small cell lung cancer cells to TRAIL-induced apoptosis
- (2012) Fei Xu et al. Chinese Journal of Cancer
- EGFR inhibitors, MHC expression and immune responses : Can EGFR inhibitors be used as immune response modifiers?
- (2012) Brian P. Pollack OncoImmunology
- Brachyury expression predicts poor prognosis at early stages of colorectal cancer
- (2011) Nerbil Kilic et al. EUROPEAN JOURNAL OF CANCER
- EGFR Inhibitors Enhanced the Susceptibility to NK Cell-mediated Lysis of Lung Cancer Cells
- (2011) Hyunsu Kim et al. JOURNAL OF IMMUNOTHERAPY
- Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
- (2011) J. Chmielecki et al. Science Translational Medicine
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Immune Promotion of Epithelial-mesenchymal Transition and Generation of Breast Cancer Stem Cells
- (2010) J. M. Reiman et al. CANCER RESEARCH
- The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
- (2010) Romaine I. Fernando et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
- (2010) R. A. Madan et al. ONCOLOGIST
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now